EP2204380 - hnRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.07.2011 Database last updated on 26.06.2024 | Most recent event Tooltip | 01.07.2011 | Application deemed to be withdrawn | published on 03.08.2011 [2011/31] | Applicant(s) | For all designated states Charité - Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin / DE | [2010/27] | Inventor(s) | 01 /
Skriner, Karl Kirchstrasse 19 10557 Berlin / DE | 02 /
Adolph, Kerstin Bambergerstrasse 53 10777 Berlin / DE | 03 /
Hollidt, Jörg Dammsmühler Strasse 49c 13158 Berlin / DE | [2010/27] | Representative(s) | Gulde & Partner Patent- und Rechtsanwaltskanzlei mbB Wallstrasse 58/59 10179 Berlin / DE | [N/P] |
Former [2010/27] | Gulde Hengelhaupt Ziebig & Schneider Patentanwälte - Rechtsanwälte Wallstrasse 58/59 10179 Berlin / DE | Application number, filing date | 08172809.9 | 23.12.2008 | [2010/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2204380 | Date: | 07.07.2010 | Language: | EN | [2010/27] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 06.04.2009 | Classification | IPC: | C07K14/43, C12N15/11 | [2010/27] | CPC: |
C07K14/47 (EP,US);
C07K7/08 (EP,US)
| Designated contracting states | (deleted) [2011/11] |
Former [2010/27] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | hnRNP-A3-verwandte Peptide und deren Verwendung zur Diagnose von rheumatoider Arthritis | [2010/27] | English: | hnRNP A3 related peptides and use thereof for diagnosis of rheumatoid arthritis | [2010/27] | French: | Peptides de type hnRNP A3 et leur utilisation pour le diagnostic de l'arthrite rhumatoïde | [2010/27] | Examination procedure | 08.01.2011 | Application deemed to be withdrawn, date of legal effect [2011/31] | 15.02.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2011/31] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.12.2010 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9814469 (US HEALTH [US], et al) [X] 1 * page 11; claim 4 *; | [X]US2003068803 (REED ROBIN [US], et al) [X] 3 * claim 24 * | [Y] - HAYER SILVIA ET AL, "Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice", JOURNAL OF IMMUNOLOGY, (200512), vol. 175, no. 12, ISSN 0022-1767, pages 8327 - 8336, XP002518173 [Y] 1-13 * Abstract and Results * | [X] - SIAPKA SORANA ET AL, "Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen", AUTOIMMUNITY, HARWOOD, CHUR, CH, (20070501), vol. 40, no. 3, ISSN 0891-6934, pages 223 - 233, XP009113371 [X] 1-13 * the whole document * DOI: http://dx.doi.org/10.1080/08916930701352357 | [Y] - SUELEYMANOGLU, E., "Circular Dichroism and Fluorescence Spectroscopic Study of RNA-protein Folding Patterns in Human hnRNP A3 and Their Implications in Human Autoimmune Diseases", PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS [PROG. BIOCHEM. BIOPHYS.], (20040300) VOL. 31, NO. 3, PP. 219-224. ISSN: 1000-3282., (2004), vol. 31, no. 3, XP002518174 [Y] 1-13 * the whole document * | [A] - STEINER G ET AL, "[Novel autoantibodies for the diagnosis of rheumatoid arthritis]", ZEITSCHRIFT FÜR RHEUMATOLOGIE DEC 2002, (200212), vol. 61, no. 6, ISSN 0340-1855, pages 667 - 673, XP002518175 [A] * page 669, column L, paragraph 1 - page 670, column R, paragraph LAST * DOI: http://dx.doi.org/10.1007/S00393-002-0470-Y | by applicant | WO2007000320 | - YOUNG, B.J.J. ET AL., "Antikeratin antibodies in rheumatoid arthritis", B.M.J., (1979), vol. 2, pages 97 - 99 | - VINCENT, C.H. ET AL., "High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called "antikeratin antibodies", ANN. RHEUMAT. DIS., (1989), vol. 48, pages 712 - 722 | - VINCENT, C.H. ET AL., "Natural IgG to Epidermal Cytokeratins vs IgG to the Stratum Corneum of the Rat Oesophagus Epithelium, so-called "Antikeratin Antibodies", in Rheumatoid Arthritis and other Rheumatic Diseases", J. OF AUTOIMMUNITY, (1991), vol. 4, doi:doi:10.1016/0896-8411(91)90161-5, pages 493 - 505, XP026263798 DOI: http://dx.doi.org/10.1016/0896-8411(91)90161-5 | - F'AIMELA, L. ET AL., "Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid Arthritis", ANN. RHEUMAT. DIS., (1992), vol. 51, pages 743 - 746 | - SIMON, M. ET AL., "The Cytokeratin Filament-Aggregating Protein Filaggrin is the Target of the So-called "Antikeratin Antibodies", Autoantibodies Specific for Rheumatoid Arthritis", J. CLIN. INVEST., (1993), vol. 92, pages 1387 - 93 | - CHOREV ET AL., TRENDS BIOTECH., (1995), vol. 13, pages 438 - 445 | - GREGORIUS, K.; MOURITSEN, S.; ELSNER, H.I., "Hydrocoating: a new method for coupling biomolecules to solid phases", J.IMMUNOL. METHODS, (1995), vol. 12, doi:doi:10.1016/0022-1759(94)00330-Y, pages 65 - 73, XP004021057 DOI: http://dx.doi.org/10.1016/0022-1759(94)00330-Y |